Beiping Miao

Mr. Beiping Miao


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2020 in Cancers
Verified
Journal Article
Open access
PDF file
ASAayushi Srivastava
Aayushi Srivastava
BMBeiping Miao
Beiping Miao
DSDiamanto Skopelitou
Diamanto Skopelitou
VKVarun Kumar
Varun Kumar
AAAbhishek A0bhishek
Abhishek A0bhishek
Obul Reddy BandapalliObul Reddy Bandapalli
Obul Reddy Bandapalli
Non-medullary thyroid cancer (NMTC) is a common endocrine malignancy with a genetic basis that has yet to be unequivocally established. In a recent whole-genome sequencing study of five families with occurrence of NMTCs, we shortlisted promising variants with the help of bioinformatics tools. Here, we report in silico analyses and in vitro experiments on a novel germline variant (p.V29L) in the highly conserved oligonucleotide/oligosaccharide binding domain of the Protection of Telomeres 1 (POT1) gene in one of the families. The results showed a reduction in telomere-bound POT1 levels in the mutant protein as compared to its wild-type counterpart. HEK293T cells carrying POT1 p.V29L showed increased telomere length in comparison to wild-type cells, suggesting that the mutation causes telomere dysfunction and may play a role in predisposition to NMTC in this family. While one germline mutation in POT1 has already been reported in a melanoma-prone family with prevalence of thyroid cancers, we report the first of such mutations in a family affected solely by NMTCs, thus expanding current knowledge on shelterin complex-associated cancers.

28 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
ZLZhu Lizhen
Zhu Lizhen
BMBeiping Miao
Beiping Miao
DDDagmara Dymerska
Dagmara Dymerska
MMMagdalena Marciniak
Magdalena Marciniak
EBElena Bueno-Martínez
Elena Bueno-Martínez
Asta FörstiAsta Försti
Asta Försti
Familial colorectal cancer (CRC) is only partially explained by known germline predisposing genes. We performed whole-genome sequencing in 15 Polish families of many affected individuals, without mutations in known CRC predisposing genes. We focused on loss-of-function variants and functionally characterized them. We identified a frameshift variant in the CYBA gene (c.246delC) in one family and a splice site variant in the TRPM4 gene (c.25–1 G > T) in another family. While both variants were absent or extremely rare in gene variant databases, we identified four additional Polish familial CRC cases and two healthy elderly individuals with the CYBA variant (odds ratio 2.46, 95% confidence interval 0.48–12.69). Both variants led to a premature stop codon and to a truncated protein. Functional characterization of the variants showed that knockdown of CYBA or TRPM4 depressed generation of reactive oxygen species (ROS) in LS174T and HT-29 cell lines. Knockdown of TRPM4 resulted in decreased MUC2 protein production. CYBA encodes a component in the NADPH oxidase system which generates ROS and controls, e.g., bacterial colonization in the gut. Germline CYBA variants are associated with early onset inflammatory bowel disease, supported with experimental evidence on loss of intestinal mucus barrier function due to ROS deficiency. TRPM4 encodes a calcium-activated ion channel, which, in a human colonic cancer cell line, controls calcium-mediated secretion of MUC2, a major component of intestinal mucus barrier. We suggest that the gene defects in CYBA and TRPM4 mechanistically involve intestinal barrier integrity through ROS and mucus biology, which converges in chronic bowel inflammation.

Verified
Journal Article
Open access
PDF file
DSDiamanto Skopelitou
Diamanto Skopelitou
BMBeiping Miao
Beiping Miao
ASAayushi Srivastava
Aayushi Srivastava
AAAbhishek A0bhishek
Abhishek A0bhishek
MMMagdalena Marciniak
Magdalena Marciniak
Obul Reddy BandapalliObul Reddy Bandapalli
Obul Reddy Bandapalli
Germline mutations in predisposition genes account for only 20% of all familial colorectal cancers (CRC) and the remaining genetic burden may be due to rare high- to moderate-penetrance germline variants that are not explored. With the aim of identifying such potential cancer-predisposing variants, we performed whole exome sequencing on three CRC cases and three unaffected members of a Polish family and identified two novel heterozygous variants: a coding variant in APC downregulated 1 gene (APCDD1, p.R299H) and a non-coding variant in the 5′ untranslated region (UTR) of histone deacetylase 5 gene (HDAC5). Sanger sequencing confirmed the variants segregating with the disease and Taqman assays revealed 8 additional APCDD1 variants in a cohort of 1705 familial CRC patients and no further HDAC5 variants. Proliferation assays indicated an insignificant proliferative impact for the APCDD1 variant. Luciferase reporter assays using the HDAC5 variant resulted in an enhanced promoter activity. Targeting of transcription factor binding sites of SNAI-2 and TCF4 interrupted by the HDAC5 variant showed a significant impact of TCF4 on promoter activity of mutated HDAC5. Our findings contribute not only to the identification of unrecognized genetic causes of familial CRC but also underline the importance of 5’UTR variants affecting transcriptional regulation and the pathogenesis of complex disorders.

Verified
Journal Article
Open access
PDF file
BMBeiping Miao
Beiping Miao
DSDiamanto Skopelitou
Diamanto Skopelitou
ASAayushi Srivastava
Aayushi Srivastava
SGSara Giangiobbe
Sara Giangiobbe
DDDagmara Dymerska
Dagmara Dymerska
Obul Reddy BandapalliObul Reddy Bandapalli
Obul Reddy Bandapalli
Colorectal cancer (CRC) is the third most frequently diagnosed malignancy worldwide. Only 5% of all CRC cases are due to germline mutations in known predisposition genes, and the remaining genetic burden still has to be discovered. In this study, we performed whole-exome sequencing on six members of a Polish family diagnosed with CRC and identified a novel germline variant in the protein tyrosine kinase 7 (inactive) gene (PTK7, ENST00000230419, V354M). Targeted screening of the variant in 1705 familial CRC cases and 1674 healthy elderly individuals identified the variant in an additional familial CRC case. Introduction of this variant in HT-29 cells resulted in increased cell proliferation, migration, and invasion; it also caused down-regulation of CREB, p21 and p53 mRNA and protein levels, and increased AKT phosphorylation. These changes indicated inhibition of apoptosis pathways and activation of AKT signaling. Our study confirmed the oncogenic function of PTK7 and supported its role in genetic predisposition of familial CRC.

14 September 2021 in Cancer Communications
Verified
Journal Article
Open access
PDF file
BMBeiping Miao
Beiping Miao
CZChaoyang Zhang
Chaoyang Zhang
NSNadine Stroh
Nadine Stroh
LBLukas Brenner
Lukas Brenner
KHKatrin Hufnagel
Katrin Hufnagel
Obul Reddy BandapalliObul Reddy Bandapalli
Obul Reddy Bandapalli
Click on the article title to read more.

29 March 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAayushi Srivastava
Aayushi Srivastava
BMBeiping Miao
Beiping Miao
DSDiamanto Skopelitou
Diamanto Skopelitou
VKVarun Kumar
Varun Kumar
AAAbhishek A0bhishek
Abhishek A0bhishek
Obul Reddy BandapalliObul Reddy Bandapalli
Obul Reddy Bandapalli
Non-medullary thyroid cancer (NMTC) is a common endocrine malignancy with a genetic basis that has yet to be unequivocally established. In a recent whole genome sequencing study of five families with recurrence of NMTCs, we shortlisted promising variants with the help of bioinformatics tools. Here, we report in silico analyses and in vitro experiments on a novel germline variant (p.V29L) in the highly conserved oligonucleotide/oligosaccharide binding domain of the Protection of Telomeres 1 (POT1) gene in one of the families. The results showed that the variant demonstrates a reduction in telomere-bound POT1 levels in the mutant protein as compared to its wild-type counterpart. HEK293Tcells carrying POT1 V29L showed increased telomere length in comparison to wild type cells, strongly suggesting that the mutation causes telomere dysfunction and may play a role in predisposition to NMTC in this family. This study reports the first germline POT1 mutation in a family with a predominance of thyroid cancer, thereby expanding the spectrum of cancers associated with mutations in the shelterin complex.